Companies Backed by Johnson & Johnson Innovation - JJDC
8 companies in Johnson & Johnson Innovation - JJDC's investment portfolio.
Back to Johnson & Johnson Innovation - JJDC profileInvestment Thesis
“Investing in revolutionary healthcare companies that have the potential to profoundly change the trajectory of health for humanity.”
Portfolio Companies (2)
Auris Health
Develops robotic systems for minimally invasive surgery, particularly for lung procedures.
Veracyte
Veracyte is a South San Francisco genomic diagnostics company whose tests cover thyroid, prostate, breast and lung cancer. It went public on Nasdaq (VCYT) in October 2013 and reported $517M in revenue for 2025.
Other Investments (6)
Portfolio Analysis
Johnson & Johnson Innovation - JJDC has built a portfolio of 8 companies across 2 sectors, including Biotech, Digital Health. Of these investments, 1 has achieved successful exits through acquisitions or IPOs, demonstrating the firm's track record of backing companies to meaningful outcomes.
The portfolio reflects investments across the IPO, Series D+ stages, showing Johnson & Johnson Innovation - JJDC's approach to supporting companies at multiple points in their growth journey.
Frequently Asked Questions
How many companies has Johnson & Johnson Innovation - JJDC invested in?
Johnson & Johnson Innovation - JJDC has invested in 8+ companies across 2 different sectors. Of these, 1 has achieved successful exits through acquisitions or IPOs.
What sectors does Johnson & Johnson Innovation - JJDC invest in?
Johnson & Johnson Innovation - JJDC's portfolio spans Biotech, Digital Health. This diversification reflects the firm's broad investment thesis and sector expertise.
What stages does Johnson & Johnson Innovation - JJDC invest at?
Johnson & Johnson Innovation - JJDC invests across the IPO, Series D+ stages. Their portfolio includes companies at various points in their growth journey.
How many exits has Johnson & Johnson Innovation - JJDC had?
Johnson & Johnson Innovation - JJDC has had 1 portfolio company achieve exits through acquisitions or IPOs. This track record of exits demonstrates the firm's ability to identify and support companies through successful outcomes.